Spire Wealth Management’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-100
Closed -$1.38K 2374
2023
Q3
$1.38K Hold
100
﹤0.01% 2200
2023
Q2
$2.21K Hold
100
﹤0.01% 2182
2023
Q1
$2.17K Sell
100
-16
-14% -$360 ﹤0.01% 2241
2022
Q4
$2K Buy
116
+16
+16% +$330 ﹤0.01% 2017
2022
Q3
$2K Hold
100
﹤0.01% 1925
2022
Q2
$1K Hold
100
﹤0.01% 2467
2022
Q1
$2K Hold
100
﹤0.01% 2374
2021
Q4
$4K Hold
100
﹤0.01% 2607
2021
Q3
$4K Hold
100
﹤0.01% 2318
2021
Q2
$4K Sell
100
-285
-74% -$10K ﹤0.01% 2345
2021
Q1
$14K Buy
+385
New +$15.2K ﹤0.01% 2291

Other funds holding BLFS

Spire Wealth Management's BLFS Position: Q4 2023 in Review

Spire Wealth Management sold out of BioLife Solutions (BLFS) in Q4 2023, closing a stake of 100 shares — an estimated $1.38K sold.

Spire Wealth Management first reported a position in BLFS in Q1 2021 and held it in 11 quarters. The position peaked at $14K in Q1 2021. 140 funds tracked by Wall St. Rank hold BLFS as of Q4 2023.

  • Spire Wealth Management reported no remaining BioLife Solutions position as of Q4 2023 after selling out during the quarter.
  • Spire Wealth Management sold 100 BioLife Solutions shares in Q4 2023, an estimated $1.38K.
  • Spire Wealth Management first reported a position in BioLife Solutions in Q1 2021 and held it in 11 quarters.
  • Spire Wealth Management's BioLife Solutions position peaked at $14K in Q1 2021.
  • 140 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2023.

Based on Spire Wealth Management's 13F filing for Q4 2023, filed 6 Feb 2024.